The effectiveness of a health education intervention to reduce anxiety in quarantined COVID-19 patients: a randomized controlled trial.
Anxiety
COVID-19
Health education
Pandemic
Quarantine
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
20 06 2023
20 06 2023
Historique:
received:
11
03
2023
accepted:
11
06
2023
medline:
22
6
2023
pubmed:
21
6
2023
entrez:
20
6
2023
Statut:
epublish
Résumé
The COVID-19 pandemic is regarded as a serious public health concern that boosts levels of stress and anxiety which could be explained by several reasons, including social isolation. In this regard, we aimed to assess the impact of health education on the anxiety level of COVID-19 patients during the isolation period. This is a randomized controlled trial conducted between February 2021 and June 2021. Patients tested positive for Covid-19 with mild to moderate forms were randomized to Education (n = 267) or control (n = 269). The education group received a phone health education session on day 1 (D1) following the diagnosis. The three components of the health education intervention were an explanation of the coronavirus disease, what to do in the event of complications, and the recommended preventive measures. The two groups received a telephone evaluation of their Hospital Anxiety and Depression scores on D1 and day seven D7 following the positive diagnosis. The primary outcome was the rate of anxiety reduction in each group on D7 based on a HAD-A score ≥ 8. Secondary outcomes were the rate of anxiety reduction on D7 based on a HAD-A score ≥ 11, the percentage of people complying with isolation and the scores of adherences to preventive measures during the isolation in each group. Hundred and ninety-six patients in the intervention group and 206 patients in the control group completed the study. The sociodemographic, clinical, and initial anxiety level features of the intervention and control groups were comparable at baseline (p ≥ 0.05). On D7, the education group's anxiety level (HAD-A ≥ 8) decreased from 26 to 16.3% (p = 0.013) while in the control group it increased from 19.4 to 22.8% (p = 0.37). Thus, the percentage change in anxiety between D1 and D7 (delta D7 - D1) was - 9.7% in the Education group and + 3.4% in the Control group. Using the HAD-A ≥ 11 thresholds, the percentage of anxiety decreased from 15.3 to 11.2% (p = 0.26) between D1 and D7, while it increased in the control group from 9.7 to 15.7% (p = 0.045). Thus, the education group's change in anxiety (delta D7 - D1) was - 4.1%, while the control group's change was + 6%. During an outbreak, providing health education to quarantined patients may be beneficial to reduce the psychological impact of the disease. ClinicalTrials.gov Identifier: NCT05715593, retrospectively registered on 8/02/2023 https://clinicaltrials.gov/ct2/results?term=NCT05715593&Search=Search .
Identifiants
pubmed: 37340300
doi: 10.1186/s12889-023-16104-w
pii: 10.1186/s12889-023-16104-w
pmc: PMC10280925
doi:
Banques de données
ClinicalTrials.gov
['NCT05715593']
Types de publication
Randomized Controlled Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1188Informations de copyright
© 2023. The Author(s).
Références
Saudi J Anaesth. 2017 May;11(Suppl 1):S11-S18
pubmed: 28616000
Psychol Res Behav Manag. 2021 May 06;14:541-548
pubmed: 33986616
Trials. 2021 Jul 13;22(1):446
pubmed: 34256810
Medicine (Baltimore). 2019 Nov;98(44):e17552
pubmed: 31689758
Perspect Psychiatr Care. 2021 Jan;57(1):246-252
pubmed: 32537821
J Affect Disord. 2021 Nov 1;294:10-16
pubmed: 34256180
Front Psychol. 2019 Nov 12;10:2504
pubmed: 31781003
Int J Environ Res Public Health. 2020 Mar 06;17(5):
pubmed: 32155789
Tunis Med. 2020 Aug-Sep;98(8-9):619-624
pubmed: 33480016
J Trop Pediatr. 2021 Jan 29;67(1):
pubmed: 33367907
Front Psychiatry. 2020 Jun 05;11:533
pubmed: 32581895
BMC Med Educ. 2021 Nov 6;21(1):563
pubmed: 34742258
Prev Sci. 2022 Oct;23(7):1208-1215
pubmed: 35157225
Behav Sci (Basel). 2022 Mar 17;12(3):
pubmed: 35323402
Death Stud. 2022;46(9):2070-2076
pubmed: 33555985
Transl Psychiatry. 2022 Jun 1;12(1):222
pubmed: 35650179
J Med Internet Res. 2020 Apr 14;22(4):e18908
pubmed: 32250962
J Glob Health. 2021 Mar 07;11:03004
pubmed: 34326984
J Nutr Health Aging. 2020;24(9):938-947
pubmed: 33155618
Ann Intern Med. 2020 Jul 21;173(2):100-109
pubmed: 32271861
Int J Soc Psychiatry. 2021 Aug;67(5):550-558
pubmed: 33040668
J Affect Disord. 2021 Dec 1;295:1335-1346
pubmed: 34706447
Cureus. 2020 Sep 14;12(9):e10453
pubmed: 33072461
BMC Med Educ. 2022 Feb 21;22(1):115
pubmed: 35189863
Int J Environ Res Public Health. 2021 Jun 14;18(12):
pubmed: 34198649
Inf Process Manag. 2022 Jul;59(4):102989
pubmed: 35673633
J Affect Disord. 2020 Oct 1;275:188-193
pubmed: 32734907
Int J Methods Psychiatr Res. 2022 Sep;31(3):e1924
pubmed: 35700080
Glob Health Res Policy. 2021 Sep 30;6(1):37
pubmed: 34593054
Medicine (Baltimore). 2019 Nov;98(44):e17667
pubmed: 31689780
Emerg Infect Dis. 2020 Jul;26(7):1616-1618
pubmed: 32202993
JMIR Mhealth Uhealth. 2021 May 18;9(5):e27039
pubmed: 33909587
Front Psychol. 2022 Mar 30;13:820288
pubmed: 35432145